Goodwin + KPMG 4th Annual Symposium @ JP Morgan
Goodwin and KPMG hosted their 4th Annual Symposium held during the 41st Annual JP Morgan Healthcare Conference week.
Life sciences companies have many opportunities to thrive in the face of changing tides. At this year's symposium in January, we delved into strategies that enable life sciences companies to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital for growth. By embracing these opportunities, life sciences companies can not only avoid getting caught in a riptide but chart new paths to success. If you missed our Symposium in person, please check the video recordings of each panel.
2023 Agenda & Videos
Dive Deeper With Goodwin
Goodwin's Life Sciences Practice
Our Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, technology-driven environment. We work with life sciences companies throughout the corporate lifecycle, as well as with investors, banks, and others in the life sciences ecosystem.
Life Sciences Perspectives
Our Life Sciences Perspectives blog is a resource specifically aimed at addressing your most frequent and pressing issues in this dynamic industry. We provide the insights you need most, including developments on private and public company matters, licensing deals and collaborations, patent and IP matters, FDA and healthcare regulatory compliance, and European and Asian developments for life sciences companies.
Get In Touch
For more information about our annual Symposium, please email jpm@goodwinlaw.com